Medical Device Leader Series

Top Companion Diagnostics (CDx) Developers, Manufacturers and Marketers in 2016 - Seite 2

Prospects for US-based developers, manufacturers and marketers
Chapter 4 profiles companion diagnostic manufacturers based in the United States. Leading companies profiled there are these seven organisations:
• Abbott Laboratories
• Myriad Genetics
• Genomic Health
• Thermo Fisher Scientific
• Johnson & Johnson
• LabCorp
• Illumina.

There you discover what the future holds, seeing how companies compare and compete. Suppliers and users of companion diagnostic systems will benefit from 2016.

Outlooks for European manufacturers of those diagnostic medical devices
Chapter 5 profiles companion diagnostic manufacturers based in Europe. Leading companies profiled there are these six firms:
• Roche
• Qiagen
• Agilent Technologies
• bioMérieux
• Siemens
• MDxHealth.

Many opportunities remain, with expanding revenues likely from 2016 to 2026. Discover what is possible, seeing how you could gain.

Potentials of developers and producers in the rest of the world
Chapter 6 profiles companion diagnostic manufacturers based in the rest of the world. Leading companies profiled there are these four organisations:
• MedGenome
• Diagnocure
• Seegene
• Savyon Diagnostics.

Our work shows you possibilities for improving those technologies and raising sales, harnessing biopharmaceuticals, gene technologies and targeted therapies, including personalised medicine. See what the present and future hold, finding how you could gain.

Forces affecting the companion diagnostics industry - what shapes its present and future?
Our report discusses pressures, opportunities and other events affecting that industry and market from 2016, including these influences:
• Biomarker discovery and technologies including genomics, pharmacogenomics, proteomics and metabolomics
• Laboratory developed tests (LDT)
• Theranostics - the fastest growing segment of the CDx market
• Partnerships and other deals, including M&A and collaborations with pharma companies including Eli Lilly, AstraZeneca, Merck, GSK, Pfizer and Novartis
• Applications in cancer therapy and other therapeutic fields
• Regulations for companion diagnostic tests - opportunities and challenges.

With our analysis you assess that industry's strengths, weaknesses, opportunities and threats. See what is happening and how to gain. That way you explore what restricts and stimulates companies developing, producing, marketing and selling those diagnostic tools.